Thirdly, variants in APOB, responsible for hypobetalipoproteinemia, were collectively observed in a high proportion of Italian patients (15%), and there was a significant enrichment in pathogenic and truncating mutations in this gene in the overall cohort of NAFLD-HCC patients. Here, APOB is linked to metabolic dysfunction-associated steatotic liver disease.